D.J. Leeming

539 citations

17 papers · 404 indexed · h-index 9

Impact in

Orthopedics and Sports Medicine top 5%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Oncology
- Bone health and treatments

Papers in ⓘ

Oncology 8
- Bone health and treatments 6
- Peptidase Inhibition and Analysis 2
Molecular Biology 5
- Bone Metabolism and Diseases 4

Co-authors: M.A. Karsdal (16 shared papers)Per Qvist (4 shared papers)Kim Henriksen (6 shared papers)I. Byrjalsen (4 shared papers)László B. Tankó (1 shared paper)Peter Alexandersen (1 shared paper)Sophie Schaller (1 shared paper)Claus Christiansen (2 shared papers)
Journals: Journal of Hepatology (5 papers)Clinical Biochemistry (2 papers)Biomarkers (1 paper)Osteoarthritis and Cartilage (1 paper)European Journal of Clinical Pharmacology (1 paper)
Partner nations: Denmark Switzerland United Kingdom

In The Last Decade

D.J. Leeming

15 papers receiving 396 citations

Peers

Countries citing papers authored by D.J. Leeming

Since Specialization

Citations

This map shows the geographic impact of D.J. Leeming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Leeming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Leeming more than expected).

Fields of papers citing papers by D.J. Leeming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Leeming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Leeming. The network helps show where D.J. Leeming may publish in the future.

Co-authors

The 25 scholars most cited alongside D.J. Leeming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D.J. Leeming Line = papers co-authored together D.J. Leeming links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice European Journal of Clinical Pharmacology ·D.J. Leeming, Peter Alexandersen, M.A. Karsdal, Per Qvist, Sophie Schaller, László B. Tankó	2006	120
2	Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development Biomarkers ·D.J. Leeming, Anne‐Christine Bay‐Jensen, Efstathios Vassiliadis, Martin R. Larsen, Kim Henriksen, M.A. Karsdal	2011	68
3	Is bone quality associated with collagen age? Osteoporosis International ·D.J. Leeming, Kim Henriksen, I. Byrjalsen, Per Qvist, S.H. Madsen, Patrick Garnero, M.A. Karsdal	2009	56
4	Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) — Assessment of corresponding epitopes Clinical Biochemistry ·D.J. Leeming, Dorthe Vang Larsen, C. Zhang, Yildiz Hi, Sanne Skovgård Veidal, Rasmus Hjorth Nielsen, Kim Henriksen, Q. Zheng, Vibeke Barkholt, B.J. Riis, I. Byrjalsen, Per Qvist, M.A. Karsdal	2010	54
5	Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation BMC Musculoskeletal Disorders ·M.A. Karsdal, I. Byrjalsen, D.J. Leeming, Claus Christiansen	2008	28
6	Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers SHILAP Revista de lepidopterología ·D.J. Leeming, Mitsuru Koizumi, Per Qvist, Vibeke Barkholt, C. Zhang, Kim Henriksen, I. Byrjalsen, M.A. Karsdal	2011	21
7	Use of Bone Turnover Markers in Clinical Osteoporosis Assessment in Women: Current Issues and Future Options Women s Health ·Kim Henriksen, D.J. Leeming, Claus Christiansen, M.A. Karsdal	2011	18
8	Estimation of serum “true collagen type III formation” (Pro-C3) levels as a marker of non-alcoholic steatohepatitis in a prospective cohort Journal of Hepatology ·D.J. Leeming, Jane I. Grove, P Kaye, Caroline L. Hoad, Susan Francis, Mette Juul Nielsen, M.A. Karsdal, Indra Neil Guha, Guruprasad P. Aithal	2017	14
9	Considerations for understanding protein measurements: Identification of formation, degradation and more pathological relevant epitopes Clinical Biochemistry ·M.A. Karsdal, Federica Genovese, Daniel Guldager Kring Rasmussen, Anne‐Christine Bay‐Jensen, Joachim Høg Mortensen, Signe Holm Nielsen, Nicholas Willumsen, Christina Jensen, Tina Manon‐Jensen, Lori L. Jennings, Alexander Lynge Reese‐Petersen, Kim Henriksen, Jannie Marie Bülow Sand, Cecilie L. Bager, D.J. Leeming	2021	12
10	Serum Pro-C3 combined with clinical parameters is superior to established serological fibrosis tests at identifying patients with advanced fibrosis among patients with non-alcoholic fatty liver disease Journal of Hepatology ·Samuel J. Daniels, Morten Nielsen, Aleksander Krag, Mohammed Eslam, M.A. Karsdal, D.J. Leeming, Joseph George	2017	5
11	True Collagen Type III Formation (Pro-C3) is Predictive of Outcome in HCV Patients with Advanced Liver Fibrosis with in the Trent Study Journal of Hepatology ·D.J. Leeming, Grace Dolman, Morten Nielsen, M.A. Karsdal, Krish Patel, William L. Irving, Indra Neil Guha	2016	3
12	Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients Journal of Hepatology ·Morten Nielsen, Douglas Thorburn, D.J. Leeming, Johannes R. Hov, Bjørn Moum, Francesca Saffioti, O.H. Gilja, K.M. Boberg, G. Mazza, Massimo Pinzani, T.H. Karlsen, M.A. Karsdal, Mette Vesterhus	2016	2
13	Peptidyl arginine deiminase inhibitor effect on hepatic fibrogenesis in a CCl4 pre-clinical model of liver fibrosis University of Southern Denmark Research Portal (University of Southern Denmark) ·Efstathios Vassiliadis, Sanne Skovgård Veidal, Maria Nicoline Baandrup Kristiansen, C. Hansen, Michael Søgaard Jørgensen, D.J. Leeming, M.A. Karsdal	2013	1
14	A Serological Marker of Collagen Type III Crosslinking Correlates Strongly with Severity of Liver Disease Journal of Hepatology ·M.A. Karsdal, Mette Juul Nielsen, Maja Thiele, Federica Genovese, Bjørn Stæhr Madsen, Janne Fuglsang Hansen, Lene Møller, Sönke Detlefsen, Ove B. Schaffalitzky de Muckadell, D.J. Leeming, Aleksander Krag	2016	1
15	A lung and kidney specific fragment of type IV collagen is associated with increased mortality in idiopathic pulmonary fibrosis Annika Hummersgaard Hansen, Thomas Skovhus Prior, D.J. Leeming, M.A. Karsdal, Jannie Marie Bülow Sand, Elisabeth Bendstrup	2022	1
16	COVID-19 Effects on Lung Extracellular Matrix Remodeling, Wound Healing, and Neutrophil Activity: A Proof-of-Concept Biomarker Study Helene W. Breisnes, D.J. Leeming, Aishath Fazleen, Jannie Marie Bülow Sand	2022	0
17	048 URINARYMARKERS, ALPHA CTX AND CTXII, ARE INDICATIVE OF OA SEVERITY AND BONE TURNOVER Osteoarthritis and Cartilage ·Janet L. Huebner, Austen Jensen, D.J. Leeming, Robert E. Coleman, G. McDaniel, M.A. Karsdal, V.B. Kraus	2010	0

About D.J. Leeming

D.J. Leeming is a scholar working on Oncology, Molecular Biology, Epidemiology, Orthopedics and Sports Medicine and Hepatology, having authored 17 papers that have together received 404 indexed citations. Recurring topics across this work include Bone health and treatments (6 papers), Bone health and osteoporosis research (4 papers), Bone Metabolism and Diseases (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Protease and Inhibitor Mechanisms (3 papers), Peptidase Inhibition and Analysis (2 papers), Cell Adhesion Molecules Research (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (121 citations), Oncology (139 citations), Immunology and Allergy (29 citations), Rheumatology (66 citations) and Cancer Research (50 citations). D.J. Leeming has collaborated with scholars based in Denmark, Switzerland and United Kingdom. Frequent co-authors include M.A. Karsdal, Per Qvist, Kim Henriksen, I. Byrjalsen, László B. Tankó, Peter Alexandersen, Sophie Schaller, Claus Christiansen, Anne‐Christine Bay‐Jensen and Efstathios Vassiliadis. Their work appears in journals such as Journal of Hepatology, Clinical Biochemistry, Biomarkers, Osteoarthritis and Cartilage and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact